Brain tumor patients get help for 'Chemo Brain' with new telehealth program
NCT ID NCT05984667
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This pilot study tested a telehealth program called C-SMART for people with primary brain tumors who have mild memory or thinking problems. The program combines cognitive rehabilitation with mindfulness training over 8 weekly sessions. Researchers enrolled 32 patients and caregivers to see if the program was feasible and acceptable, and to gather early feedback.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- C-SMART (cognitive rehabilitation and mindfulness training)
- What this could lead to
- If this program works, it could offer a practical way to help brain tumor patients manage thinking and memory problems at home.
- What could go wrong
- This is a very small, early pilot study (32 people) focused on whether the program is feasible and acceptable, not on whether it actually improves symptoms. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Childhood brain tumor survivors face hidden hormone risks years later
- Digital tests may offer a new way to track brain health in tumor patients
- Mapping the hidden toll of brain radiation on young minds
- Scientists create detailed brain maps to protect language during surgery
- Could a cancer drug shrink recurrent brain tumors?